207 related articles for article (PubMed ID: 21605656)
21. Pmp-like proteins Pls1 and Pls2 are secreted into the lumen of the Chlamydia trachomatis inclusion.
Jorgensen I; Valdivia RH
Infect Immun; 2008 Sep; 76(9):3940-50. PubMed ID: 18591235
[TBL] [Abstract][Full Text] [Related]
22. Isolates of Chlamydia trachomatis that occupy nonfusogenic inclusions lack IncA, a protein localized to the inclusion membrane.
Suchland RJ; Rockey DD; Bannantine JP; Stamm WE
Infect Immun; 2000 Jan; 68(1):360-7. PubMed ID: 10603409
[TBL] [Abstract][Full Text] [Related]
23. Altered protein secretion of Chlamydia trachomatis in persistently infected human endocervical epithelial cells.
Wang J; Frohlich KM; Buckner L; Quayle AJ; Luo M; Feng X; Beatty W; Hua Z; Rao X; Lewis ME; Sorrells K; Santiago K; Zhong G; Shen L
Microbiology (Reading); 2011 Oct; 157(Pt 10):2759-2771. PubMed ID: 21737500
[TBL] [Abstract][Full Text] [Related]
24. Characterization of a secreted Chlamydia protease.
Shaw AC; Vandahl BB; Larsen MR; Roepstorff P; Gevaert K; Vandekerckhove J; Christiansen G; Birkelund S
Cell Microbiol; 2002 Jul; 4(7):411-24. PubMed ID: 12102687
[TBL] [Abstract][Full Text] [Related]
25. Peptidase Inhibitor 15 (PI15) Regulates Chlamydial CPAF Activity.
Prusty BK; Chowdhury SR; Gulve N; Rudel T
Front Cell Infect Microbiol; 2018; 8():183. PubMed ID: 29900129
[TBL] [Abstract][Full Text] [Related]
26. The hypothetical protein CT813 is localized in the Chlamydia trachomatis inclusion membrane and is immunogenic in women urogenitally infected with C. trachomatis.
Chen C; Chen D; Sharma J; Cheng W; Zhong Y; Liu K; Jensen J; Shain R; Arulanandam B; Zhong G
Infect Immun; 2006 Aug; 74(8):4826-40. PubMed ID: 16861671
[TBL] [Abstract][Full Text] [Related]
27. Plasmid Negative Regulation of CPAF Expression Is Pgp4 Independent and Restricted to Invasive
Patton MJ; Chen CY; Yang C; McCorrister S; Grant C; Westmacott G; Yuan XY; Ochoa E; Fariss R; Whitmire WM; Carlson JH; Caldwell HD; McClarty G
mBio; 2018 Jan; 9(1):. PubMed ID: 29382731
[No Abstract] [Full Text] [Related]
28. CD1d degradation in Chlamydia trachomatis-infected epithelial cells is the result of both cellular and chlamydial proteasomal activity.
Kawana K; Quayle AJ; Ficarra M; Ibana JA; Shen L; Kawana Y; Yang H; Marrero L; Yavagal S; Greene SJ; Zhang YX; Pyles RB; Blumberg RS; Schust DJ
J Biol Chem; 2007 Mar; 282(10):7368-75. PubMed ID: 17215251
[TBL] [Abstract][Full Text] [Related]
29. A Chlamydia trachomatis OmcB C-terminal fragment is released into the host cell cytoplasm and is immunogenic in humans.
Qi M; Gong S; Lei L; Liu Q; Zhong G
Infect Immun; 2011 Jun; 79(6):2193-203. PubMed ID: 21422182
[TBL] [Abstract][Full Text] [Related]
30. Cleavage of the NF-κB family protein p65/RelA by the chlamydial protease-like activity factor (CPAF) impairs proinflammatory signaling in cells infected with Chlamydiae.
Christian J; Vier J; Paschen SA; Häcker G
J Biol Chem; 2010 Dec; 285(53):41320-7. PubMed ID: 21041296
[TBL] [Abstract][Full Text] [Related]
31. Conserved type III secretion system exerts important roles in Chlamydia trachomatis.
Dai W; Li Z
Int J Clin Exp Pathol; 2014; 7(9):5404-14. PubMed ID: 25337183
[TBL] [Abstract][Full Text] [Related]
32. Persistent Chlamydia trachomatis infection of HeLa cells mediates apoptosis resistance through a Chlamydia protease-like activity factor-independent mechanism and induces high mobility group box 1 release.
Rödel J; Grosse C; Yu H; Wolf K; Otto GP; Liebler-Tenorio E; Forsbach-Birk V; Straube E
Infect Immun; 2012 Jan; 80(1):195-205. PubMed ID: 22025513
[TBL] [Abstract][Full Text] [Related]
33. The secreted protease factor CPAF is responsible for degrading pro-apoptotic BH3-only proteins in Chlamydia trachomatis-infected cells.
Pirbhai M; Dong F; Zhong Y; Pan KZ; Zhong G
J Biol Chem; 2006 Oct; 281(42):31495-501. PubMed ID: 16940052
[TBL] [Abstract][Full Text] [Related]
34. Developmental stage oxidoreductive states of Chlamydia and infected host cells.
Wang X; Schwarzer C; Hybiske K; Machen TE; Stephens RS
mBio; 2014 Oct; 5(6):e01924. PubMed ID: 25352618
[TBL] [Abstract][Full Text] [Related]
35. Chlamydia-secreted protease CPAF degrades host antimicrobial peptides.
Tang L; Chen J; Zhou Z; Yu P; Yang Z; Zhong G
Microbes Infect; 2015 Jun; 17(6):402-8. PubMed ID: 25752416
[TBL] [Abstract][Full Text] [Related]
36. Human antibody responses to a Chlamydia-secreted protease factor.
Sharma J; Bosnic AM; Piper JM; Zhong G
Infect Immun; 2004 Dec; 72(12):7164-71. PubMed ID: 15557641
[TBL] [Abstract][Full Text] [Related]
37. Analysis of CPAF mutants: new functions, new questions (the ins and outs of a chlamydial protease).
Bavoil PM; Byrne GI
Pathog Dis; 2014 Aug; 71(3):287-91. PubMed ID: 24942261
[TBL] [Abstract][Full Text] [Related]
38. Characterization of CPAF critical residues and secretion during Chlamydia trachomatis infection.
Yang Z; Tang L; Sun X; Chai J; Zhong G
Infect Immun; 2015 Jun; 83(6):2234-41. PubMed ID: 25776755
[TBL] [Abstract][Full Text] [Related]
39. Ultrastructural analysis of chlamydial antigen-containing vesicles everting from the Chlamydia trachomatis inclusion.
Giles DK; Whittimore JD; LaRue RW; Raulston JE; Wyrick PB
Microbes Infect; 2006 May; 8(6):1579-91. PubMed ID: 16698305
[TBL] [Abstract][Full Text] [Related]
40. CPAF: a Chlamydial protease in search of an authentic substrate.
Chen AL; Johnson KA; Lee JK; Sütterlin C; Tan M
PLoS Pathog; 2012; 8(8):e1002842. PubMed ID: 22876181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
